Eluxadoline-Loaded Eudragit Nanoparticles for Irritable Bowel Syndrome with Diarrhea: Formulation, Optimization Using Box-Behnken Design, and Anti-Diarrheal Activity.

Anwer, Md Khalid; Ahmed, Mohammed Muqtader; Aldawsari, Mohammed F; Iqbal, Muzaffar; Soliman, Gamal A; Aljuffali, Ibrahim A

Anwer, Md Khalid; Ahmed, Mohammed Muqtader; Aldawsari, Mohammed F; Iqbal, Muzaffar; Soliman, Gamal A; Aljuffali, Ibrahim A.

Afiliación

Anwer MK; Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Ahmed MM; Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Aldawsari MF; Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Iqbal M; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Soliman GA; Bioavailability Laboratory, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Aljuffali IA; Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.

Pharmaceutics ; 15(5)2023 May 10.

Article en En | MEDLINE | ID: mdl-37242700

Palabras clave

defecation frequency; disease activity index; dissolution; eluxadoline; eudragit; optimization

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google